Labcorp Holdings在2026年第一季度表现强劲,营收较去年同期增长5.8%。这一增长得益于有机扩张、收购以及有利的外汇影响的综合作用。诊断实验室和生物制药实验室服务两个部门均为这一积极表现做出了贡献,营收和营业收入均显著增加。 Labcorp 2026年第一季度每股收益$4.25超过预期的$4.12,实现3.16%的盈利超预期。这一表现延续了该公司超越市场预期的趋势,反映出有效的运营 ...

Labcorp Holdings Inc. (LH)公布的2026年第一季度业绩超出预期,调整后每股收益为$4.25,高于预期的$4.12。该公司营收也超出预期,达到35.4亿美元,高于预期的35.1亿美元。受此业绩提振,Labcorp股价在盘前交易中上涨2.64%,反映出投资者对该公司业绩表现和未来前景的信心。 Labcorp Holdings在2026年第一季度表现稳健,两大核心业务板块均对增 ...

Q1 2026 earnings call: revenue +6%, EPS +11%, margin gains and raised 2026 guidance amid policy risks (PAMA/ACA).

As LabCorp reports a 5.8% revenue jump in Q1 2026 and athenahealth deepens its FHIR R4 integration capabilities, the gap between clinical research needs and standard EHR workflows is widening.

BURLINGTON, N.C., March 31, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the first ...

With me today are Adam Schechter, our Chairman and Chief Executive Officer; and Julia Wang, our Executive Vice President and ...

Unified order view: Labcorp Link’s enhanced tracking consolidates all lab orders into one interface, boosting transparency and reducing follow-up time. Targeting missed tests: Open Orders programs use ...

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be reporting results this Thursday before market open. Here’s ...